134 related articles for article (PubMed ID: 10805292)
21. [Analysis of hemostatic abnormality in various disease using molecular-I. Liver disease].
Shimazu C; Fukuda T; Yugeta N; Yasuda K; Wakasugi K; Tahara C; Miyajima Y; Kazama M
Rinsho Byori; 1991 Mar; 39(3):295-301. PubMed ID: 1828841
[TBL] [Abstract][Full Text] [Related]
22. D-dimer and thrombin-antithrombin III complex levels uncorrelated with phlebographic findings in 11 total knee replacement patients.
De Prost D; Ollivier V; Vie P; Benacerraf R; Duparc J; Khoury A
Ann Biol Clin (Paris); 1990; 48(4):235-8. PubMed ID: 2193559
[TBL] [Abstract][Full Text] [Related]
23. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
24. [Laboratory diagnosis of left atrial thrombi in patients with mitral stenosis].
Hayashi I
Fukuoka Igaku Zasshi; 1991 Nov; 82(11):550-61. PubMed ID: 1774012
[TBL] [Abstract][Full Text] [Related]
25. Disseminated intravascular coagulation in transfusion-associated graft-versus-host disease. Report of two cases.
Murakawa M; Okamura T; Harada M; Esaki T; Kamura T; Shibuya T; Niho Y
Ann Clin Lab Sci; 1995; 25(1):31-8. PubMed ID: 7762966
[TBL] [Abstract][Full Text] [Related]
26. D-dimer and thrombin-antithrombin III complexes in patients with clinically suspected pulmonary embolism.
Demers C; Ginsberg JS; Johnston M; Brill-Edwards P; Panju A
Thromb Haemost; 1992 Apr; 67(4):408-12. PubMed ID: 1631787
[TBL] [Abstract][Full Text] [Related]
27. Hemostasis activation in patients with liver cirrhosis.
Vukovich T; Teufelsbauer H; Fritzer M; Kreuzer S; Knoflach P
Thromb Res; 1995 Feb; 77(3):271-8. PubMed ID: 7740519
[TBL] [Abstract][Full Text] [Related]
28. [Changes in the activation markers of blood coagulation and fibrinolysis in the neonatal period].
Ries M; Klinge J; Rauch R; Zenker M; Aydin I; Harms D
Klin Padiatr; 1996; 208(6):350-4. PubMed ID: 9064377
[TBL] [Abstract][Full Text] [Related]
29. Hypercoagulable state under low-intensity warfarin anticoagulation assessed with hemostatic markers in cardiac disorders.
Takano K; Iino K; Ibayashi S; Tagawa K; Sadoshima S; Fujishima M
Am J Cardiol; 1994 Nov; 74(9):935-9. PubMed ID: 7977125
[TBL] [Abstract][Full Text] [Related]
30. Evaluating prethrombotic state in lung cancer using molecular markers.
Gabazza EC; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Chest; 1993 Jan; 103(1):196-200. PubMed ID: 7678080
[TBL] [Abstract][Full Text] [Related]
31. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
Oikawa T; Muramatsu Y; Akashi S; Usui N
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):144-9. PubMed ID: 9134831
[TBL] [Abstract][Full Text] [Related]
32. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
[TBL] [Abstract][Full Text] [Related]
33. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
Kario K; Matsuo T
Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
[TBL] [Abstract][Full Text] [Related]
34. Significance of hemostatic molecular markers during disseminated intravascular coagulation in patients with liver cirrhosis treated by endoscopic embolization for esophageal varices.
Koyama T; Kakishita E; Nakai Y; Okamoto E
Am J Hematol; 1991 Oct; 38(2):90-4. PubMed ID: 1719808
[TBL] [Abstract][Full Text] [Related]
35. Increased tissue factor pathway inhibitor in patients with acute myocardial infarction.
Kamikura Y; Wada H; Yamada A; Shimura M; Hiyoyama K; Shiku H; Tanigawa M; Nishikawa H; Yamada N; Isaka N; Nakano T; Kumeda K; Kato H
Am J Hematol; 1997 Aug; 55(4):183-7. PubMed ID: 9257877
[TBL] [Abstract][Full Text] [Related]
36. Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers.
Ito T; Tanouchi J; Kato J; Nishino M; Iwai K; Tanahashi H; Hori M; Yamada Y; Kamada T
Angiology; 1997 Oct; 48(10):901-6. PubMed ID: 9342969
[TBL] [Abstract][Full Text] [Related]
37. Markers of in vivo activation of coagulation. Interrelationships change with intensity of oral anticoagulation.
Solymoss S; Bovill EG
Am J Clin Pathol; 1996 Mar; 105(3):293-7. PubMed ID: 8602609
[TBL] [Abstract][Full Text] [Related]
38. Hemostasis in newborns of smoking and nonsmoking mothers.
Mercelina-Roumans PE; Ubachs JM; van Wersch JW
Am J Obstet Gynecol; 1997 Mar; 176(3):662-6. PubMed ID: 9077625
[TBL] [Abstract][Full Text] [Related]
39. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680
[TBL] [Abstract][Full Text] [Related]
40. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy.
Mitusch R; Siemens HJ; Garbe M; Wagner T; Sheikhzadeh A; Diederich KW
Thromb Haemost; 1996 Feb; 75(2):219-23. PubMed ID: 8815563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
